Immix Biopharma (IMMX) Debt Ratio (2020 - 2022)
Immix Biopharma (IMMX) posted Debt Ratio of 7.51 for Q4 2020.
Powered by 
Analysis
Immix Biopharma (IMMX) Debt Ratio (2020 - 2022) Analysis & Trends
Immix Biopharma has reported Debt Ratio for 1 years, with the latest figure at 7.51 in Q4 2020.
- Quarterly Debt Ratio changed N/A year-over-year to 7.51 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 7.51 (changed N/A YoY) and the FY2020 annual result came in at 7.51, changed N/A from the prior year.
- Debt Ratio held at 7.51 in Q4 2020 per IMMX's latest filing.
- Over five years, Debt Ratio peaked at 7.51 in Q4 2020 and troughed at 7.51 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.05 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.47 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.26 |
| 10 | Immix Biopharma | 889.29 Mn | 889.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Dec 31, 2020 | 8.57 |